EUVIMEDEUVIMED entdecken
Crossref

Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury

Trevor S Wendt iD, Rayna J Gonzales iD

American Journal of Physiology-Cell Physiology · 2023

DOI: 10.1152/ajpcell.00342.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Trevor S Wendt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 142 Literaturangaben. Gefördert von: American Heart Association-American Stroke Association, Valley Research Partnership, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have identified a potential novel mechanism by which ozanimod, a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, attenuates hypoxia plus glucose deprivation (HGD)-induced matrix metalloproteinase-9 (MMP-9) activity and disruptions in integral human brain endothelial cell barrier proteins. Our results suggest that ischemic-like injury elicits increased MMP-9 activity and alterations of barrier integrity proteins in human brain microvascular endothelial cells (HBMECs) and that ozanimod via S1PR1 attenuates these HGD-induced responses, adding to its therapeutic potential in cerebrovascular protection during the acute phase of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeStrokeHumansMaleBlood-Brain BarrierMatrix Metalloproteinase 9Sphingosine-1-Phosphate ReceptorsEndothelial CellsClaudin-5Platelet Endothelial Cell Adhesion Molecule-1IschemiaHypoxiaGlucoseIndansOxadiazoles

Stichwörter der Autor:innen

MMP-9human brain endothelial cellischemic injuryozanimodsphingosine-1-phosphate receptor 1

Substanzen

Matrix Metalloproteinase 9Sphingosine-1-Phosphate ReceptorsClaudin-5Platelet Endothelial Cell Adhesion Molecule-1GlucoseozanimodIndansOxadiazoles

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States.

ORCID-Profile: Trevor S Wendt, Rayna J Gonzales

Förderung

  • American Heart Association-American Stroke Association
  • Valley Research Partnership
  • American Heart Association

Zitieren

APA

Wendt, T. S., & Gonzales, R. J. (2023). Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00342.2023

Vancouver

Wendt TS, Gonzales RJ. Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00342.2023

BibTeX
@article{Wendt2023,
  author = {Wendt, Trevor S and Gonzales, Rayna J},
  title = {Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  doi = {10.1152/ajpcell.00342.2023}
}
Kostenlos starten →